Arcturus Therapeutics
Biotechnology, Science CTR Dr, San Diego, , 92121, California, 10628, United States, 51-200 Employees
Phone Number: 85********
Who is ARCTURUS THERAPEUTICS
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global late-stage clinical mRNA medicines and vaccines company with enabling te...
Read More
-
Headquarters: 10628 Science CTR Dr, San Diego, California, 92121, United States
-
Date Founded: 2013
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 541715 |
Show More
Does something look wrong? Fix it. | View contact records from ARCTURUS THERAPEUTICS
Arcturus Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Arcturus Therapeutics
Answer: Arcturus Therapeutics's headquarters are located at Science CTR Dr, San Diego, , 92121, California, 10628, United States
Answer: Arcturus Therapeutics's phone number is 85********
Answer: Arcturus Therapeutics's official website is https://arcturusrx.com
Answer: Arcturus Therapeutics's revenue is $25 Million to $50 Million
Answer: Arcturus Therapeutics's SIC: 2834
Answer: Arcturus Therapeutics's NAICS: 541715
Answer: Arcturus Therapeutics has 51-200 employees
Answer: Arcturus Therapeutics is in Biotechnology
Answer: Arcturus Therapeutics contact info: Phone number: 85******** Website: https://arcturusrx.com
Answer: Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a global late-stage clinical mRNA medicines and vaccines company with enabling technologies: (i) LUNAR lipid-mediated delivery, (ii) STARR mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. The Company has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase deficiency and cystic fibrosis, along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus technologies are covered by its extensive patent portfolio (patents and patent applications issued in the U.S., Europe, Japan, China, and other countries).
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month